Dr. Yeh will oversee the continued clinical development of NGM Bio’s key programs, NGM120 for hyperemesis gravidarum and cancer cachexia, and aldafermin for primary sclerosing cholangitis SOUTH SAN ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback